来凯医药-B(02105)涨超9%，公司完成配售净筹约5.77亿港元，拟用于推进ActRII产品组合开发。 小鹏汽车-W(09868)再涨超6%,，小鹏宣布进入欧洲五国市场，奥地利工厂首批新车量产下线。 智通财经APP获悉，港股恒生指数跌0.65%，跌171点，报26312点；恒生科技指数跌1.04%。港股早盘成 交1655亿港元。 摩根士丹利上调中国风电行业评级，其认为反内卷努力后板块或迎来复苏。风电股逆市走高，金风科技 (02208)涨4.6%，大唐新能源(01798)涨超1.5%。 内房股集体拉升，北上深此前优化地产政策，多个新一线城市正谋划激发改善性住房需求新政。龙湖集 团(00960)涨2.3%；万科企业(02202)涨2.42%；碧桂园(02007)涨3.5%。 华虹半导体(01347)涨4.8%创新高，近期宣布与华力微重组，高盛称公司已与客户谈判涨价。 网龙(00777)一度涨超13%，公司多款游戏将于下半年上线海外，核心IP优化后有望实现增长。 博雷顿（01333）涨超20%，与一矿业建设集团签署战略合作，推进矿山运输智能化发展。 方舟健客(06086)涨超7%，杏石医疗大模型登上Nature ...

天眼查App显示，近日，河南予美希医疗设备有限公司成立，法定代表人为殷毓徽，注册资本100万人 民币，经营范围为一般项目：第一类医疗器械销售；第二类医疗器械销售；卫生用品和一次性使用医疗 用品销售；个人卫生用品销售；卫生洁具销售；医护人员防护用品零售；医用口罩零售；针纺织品及原 料销售；卫生用杀虫剂销售；玻璃仪器销售；玻璃纤维及制品销售；电子产品销售；专业保洁、清洗、 消毒服务；消毒剂销售（不含危险化学品）；日用化学产品销售；计算机软硬件及辅助设备零售；机械 设备销售；养生保健服务（非医疗）；中医养生保健服务（非医疗）；技术服务、技术开发、技术咨 询、技术交流、技术转让、技术推广；专用设备修理；第一类医疗设备租赁；第二类医疗设备租赁（除 依法须经批准的项目外，凭营业执照依法自主开展经营活动）。 ...

Core Viewpoint - The stock price of United Imaging Healthcare has experienced fluctuations, with a recent decline of 2.00% on September 26, 2023, while the company has shown a year-to-date increase of 15.40% [1][2]. Financial Performance - For the first half of 2025, United Imaging Healthcare reported a revenue of 6.016 billion yuan, representing a year-on-year growth of 12.79%, and a net profit attributable to shareholders of 998 million yuan, which is a 5.03% increase compared to the previous year [2]. - The company has distributed a total of 534 million yuan in dividends since its A-share listing [3]. Stock Market Activity - As of September 26, 2023, the stock price was 145.77 yuan per share, with a total market capitalization of 120.138 billion yuan [1]. - The trading volume on that day was 405 million yuan, with a turnover rate of 0.33% [1]. - There was a net outflow of 26.2686 million yuan in principal funds, with large orders accounting for 24.25% of purchases and 27.33% of sales [1]. Shareholder Structure - As of June 30, 2025, the number of shareholders decreased by 23.01% to 16,500, while the average circulating shares per person increased by 29.89% to 35,953 shares [2]. - Major shareholders include the Huaxia SSE STAR 50 ETF, which increased its holdings by 3.2169 million shares, and the Hong Kong Central Clearing Limited, which raised its stake by 781.97 thousand shares [3].

光子CT还可精准应用于临床。"它不仅具备超高清晰度，还支持多能量光谱成像与物质分离功能， 可精准判定斑块性质、识别肿瘤组织成分，甚至实现无创血管成像。"张建军说，在冠心病诊断方面， 光子CT能清晰显示支架内再狭窄、微钙化及弥漫病变；在神经系统疾病检测方面，可用于筛查脑动脉 瘤、血管畸形等早期病变；还可用于痛风石检测、肿瘤定性分析等。"这台设备就像临床医生的'超级显 微镜'，它不仅提升了诊断准确性，更重要的是能发现传统CT无法识别的早期病变，帮助实现早发现、 早诊断、早治疗。" 多项高精尖技术共建新诊疗生态 "灵隐院区聚焦保健、医养、康复，三墩院区以老年医学为核心。光子CT在老年心脑血管疾病、肿 瘤早期筛查等方面具有显著优势，符合医院发展定位和患者需求。"浙江医院党委书记陈军表示，该设 备的引入将进一步增强医院的竞争力，为杭州甚至全国患者提供更优质的医疗服务。 据了解，除了光子CT，近期浙江医院还引进了多台高端医疗设备。"配备了3.0T磁共振、双平板 DSA等设备，结合AI人工智能辅助诊断，构建起一套高精度、低创伤、高效率的完整诊疗体系。"浙江 医院党委副书记、副院长万曙介绍，这些设备在心脑血管疾病、肿瘤等方面 ...

Core Insights - The report highlights that the company, Mindray Medical, experienced a decline in performance during the first half of 2025, with revenue of 16.743 billion yuan, a year-on-year decrease of 18.45%, and a net profit of 5.069 billion yuan, down 32.96% [2][6][7] - Despite the challenges faced in the first half, there is optimism for a turnaround in the third quarter, driven by a recovery in domestic medical equipment bidding activities and growth in international business [6][7][8] Financial Performance - In the second quarter of 2025, the company reported a revenue of 8.506 billion yuan, a decrease of 23.77% year-on-year, and a net profit of 2.420 billion yuan, down 44.55% [7] - The decline in performance is attributed to factors such as medical anti-corruption measures, tight local fiscal funding, and a reduction in the issuance of special medical bonds, which delayed the bidding for medical equipment updates [7] International Business Growth - The company's international business revenue increased by 5.39% year-on-year, accounting for approximately 50% of total revenue [8] - Mindray Medical is enhancing its international in-vitro diagnostic business through local platform construction and has established localized production projects in 14 countries [8][9] Technological Advancements - The company has launched the world's first clinical application of a severe medical AI model, indicating significant advancements in integrating AI into clinical practices [9] - Mindray Medical is building a digital healthcare ecosystem that combines equipment, IT, and AI, aiming for personalized and high-quality medical services [9]

Group 1 - The European Union (EU) has a significant dependency on China for rare earth materials, with 82% of its imports coming from China, which is critical for various manufacturing sectors including automotive and renewable energy [4][6]. - The recent arrival of 2,582 tons of rare earth materials has temporarily alleviated supply chain pressures in Europe, which had been exacerbated by previous shortages [4][6]. - Despite this dependency, the EU has moved forward with sanctions against 12 Chinese companies, indicating a complex geopolitical strategy that balances internal and external pressures [10][13]. Group 2 - The EU's sanctions appear to be a response to pressure from the United States, aiming to demonstrate alignment with U.S. foreign policy while managing internal divisions among member states [10][11]. - The sanctions are seen as a way to prepare for potential technological decoupling from China, as the EU recognizes its reliance on Chinese technology and aims to slow China's technological advancements [13][19]. - The EU's approach has sparked internal dissent, particularly from countries like Germany and France, who view the sanctions as a gamble with economic interests [14][21]. Group 3 - China's response to the EU's sanctions has been measured, involving strategic delays in rare earth export approvals and the suspension of certain technical cooperation projects, which applies pressure without escalating conflict [16][18]. - The EU faces a challenging reality where its economic ties with China are substantial, with trade amounting to $847.3 billion, making it difficult to sever these connections without significant economic repercussions [19][21]. - The inherent contradictions in the EU's sanctions strategy highlight the complexities of global interdependence, suggesting that a cooperative approach may be more beneficial in the long run [23][25].

此次美国商务部开展调查的依据依旧是《贸易扩展法》第232条款，此前美国政府已动用该条款对汽车 及其零部件、铜、钢和铝加征了关税，同时，针对药品、半导体、中重型卡车等产品的进口调查仍在进 行。若这些行业性调查最终导致加征关税，将与美国此前按国别征收的关税叠加执行。 本轮调查正值各贸易伙伴艰难推进与美国的关税谈判之际，各经济体进展不一。当地时间周三，美国政 府发布公告，确认美欧贸易协议生效，意味着7月底美欧达成的框架协议时隔两个月正式实施。不过据 彭博社24日报道，欧盟委员会负责贸易和经济安全的委员谢夫乔维奇本周将在吉隆坡东盟部长级峰会期 间会晤美国贸易代表格里尔，希望重启陷入停滞的钢铁和铝出口关税谈判。 【环球时报报道 记者 李迅典】美国商务部9月24日证实，美国政府已对机器人、工业机械以及医疗设备 进口启动了新一轮的"232条款"调查，以评估此类进口是否威胁美国国家安全。据美国CNBC网站25日 报道，该调查于9月2日开始，但直至本周才被披露，此举可能成为新一轮行业关税的依据，或将增加消 费者、医院、患者以及制造商需要承担的成本。 格里尔周三表示，美国预计将在未来数月内与更多东南亚国家敲定贸易协议。路透社报道 ...

U.S. medtech stocks fell on Thursday after the U.S. Commerce Department opened a probe into imports of medical devices, a move that could ultimately lead to tariffs. ...

Group 1 - The Trump administration has initiated Section 232 investigations into imported robots, industrial machinery, and medical devices, aiming to encourage domestic manufacturing by increasing import costs [1][2][4] - The investigations are based on the Trade Expansion Act of 1962, which allows the U.S. Department of Commerce to investigate imports that threaten national security, with a deadline of 270 days for policy recommendations [2][3] - The new investigations expand the range of industries potentially facing tariffs, including robots, CNC machining centers, and personal protective equipment (PPE) [2][3] Group 2 - The Trump administration's tariffs on steel, aluminum, and copper have generated significant revenue, with July 2023 tariff income reaching $28.44 billion, a 273% increase year-over-year [4] - Despite the increase in tariff revenue, the core objectives of the tariffs are to reduce the trade deficit and promote the return of manufacturing jobs to the U.S. [4][5] - The manufacturing sector has faced challenges, with job growth in manufacturing being negative since April 2023, indicating difficulties in bringing manufacturing back to the U.S. [5][6] Group 3 - Legal challenges to the Trump administration's tariff measures have emerged, with a ruling stating that the use of the International Emergency Economic Powers Act to impose tariffs was unlawful [6][7] - The ruling may impact the administration's ability to implement tariffs under this act, while Section 232 tariffs could be more enduring despite a longer implementation process [7][8] - The National Economic Council has suggested that if the Supreme Court does not support the Trump administration, other legal bases for imposing tariffs may still be pursued [7]

Group 1 - The Trump administration is initiating national security investigations into imports of robotics, industrial machinery, and medical devices, which may lead to future tariffs on these products [1] - In the medical sector, the products under scrutiny include prescription drugs, syringes, and imported medical equipment such as wheelchairs, pacemakers, and insulin pumps [1] - The Commerce Department is soliciting feedback from affected companies to assess whether domestic production can satisfy US demand [1] Group 2 - There is a growing concern about potential shortages in critical medical supplies, emphasizing the need for increased manufacturing within the United States [2]